Studies how treatments and patient factors affect thyroid cancer outcomes

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people who have been diagnosed with thyroid cancer. It studies how clinical factors and treatments affect their outcome.

Sex

All sexes can join.

Disease stage

Thyroid cancer diagnosis. No specific stage is named.

Main reasons for not taking part

• People who are unable to sign the informed consent form cannot join.

The registry criteria, word for word

What the trial wants to find out

DTC has a generally favorable prognosis. The possibility to discriminate between patients with aggressive tumors and those with a more indolent behavior may reduce the need for unnecessary treatments. Aim of this observational study is to evaluate how anamnestic, clinical, and histopathological variables may influence the outcome of the enrolled patients, both regarding morbidity and mortality and in terms of therapeutic choices. The study aims to evaluate the prognostic impact of the therapeutic interventions in terms of efficacy and regarding the appearance of adverse events.